BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10037193)

  • 1. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells.
    Tillman DM; Petak I; Houghton JA
    Clin Cancer Res; 1999 Feb; 5(2):425-30. PubMed ID: 10037193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
    Petak I; Tillman DM; Houghton JA
    Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
    Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
    Schwartzberg LS; Petak I; Stewart C; Turner PK; Ashley J; Tillman DM; Douglas L; Tan M; Billups C; Mihalik R; Weir A; Tauer K; Shope S; Houghton JA
    Clin Cancer Res; 2002 Aug; 8(8):2488-98. PubMed ID: 12171874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells.
    Petak I; Tillman DM; Harwood FG; Mihalik R; Houghton JA
    Cancer Res; 2000 May; 60(10):2643-50. PubMed ID: 10825136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression.
    Xu X; Fu XY; Plate J; Chong AS
    Cancer Res; 1998 Jul; 58(13):2832-7. PubMed ID: 9661898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts.
    Ciccolini J; Peillard L; Evrard A; Cuq P; Aubert C; Pelegrin A; Formento P; Milano G; Catalin J
    Clin Cancer Res; 2000 Apr; 6(4):1529-35. PubMed ID: 10778986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
    Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
    Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of apoptosis after thymineless stress is conferred by oncogenic K-Ras in colon carcinoma cells.
    Houghton JA; Ebanks R; Harwood FG; Tillman DM
    Clin Cancer Res; 1998 Nov; 4(11):2841-8. PubMed ID: 9829751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
    Chu E; Zinn S; Boarman D; Allegra CJ
    Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
    Huang Y; Horvath CM; Waxman S
    Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF combined with IFN-alpha accelerates NF-kappaB-mediated apoptosis through enhancement of Fas expression in colon cancer cells.
    Kimura M; Haisa M; Uetsuka H; Takaoka M; Ohkawa T; Kawashima R; Yamatsuji T; Gunduz M; Kaneda Y; Tanaka N; Naomoto Y
    Cell Death Differ; 2003 Jun; 10(6):718-28. PubMed ID: 12761580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha and interferon-gamma induce expression of functional Fas ligand on HT29 and MCF7 adenocarcinoma cells.
    Naujokat C; Sezer O; Possinger K
    Biochem Biophys Res Commun; 1999 Nov; 264(3):813-9. PubMed ID: 10544014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymineless death in colon carcinoma cells is mediated via fas signaling.
    Houghton JA; Harwood FG; Tillman DM
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8144-9. PubMed ID: 9223329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fas signaling pathway is functional in colon carcinoma cells and induces apoptosis.
    Houghton JA; Harwood FG; Gibson AA; Tillman DM
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2205-9. PubMed ID: 9815616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells.
    Tillman DM; Harwood FG; Gibson AA; Houghton JA
    Cell Death Differ; 1998 May; 5(5):450-7. PubMed ID: 10200495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo activation of invariant V alpha 14 natural killer T cells by alpha-galactosylceramide sequentially induces Fas-dependent and -independent cytotoxicity.
    Lisbonne M; Hachem P; Tonanny MB; Fourneau JM; Sidobre S; Kronenberg M; Van Endert P; Dy M; Schneider E; Leite-de-Moraes MC
    Eur J Immunol; 2004 May; 34(5):1381-8. PubMed ID: 15114671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro.
    Badie B; Schartner J; Vorpahl J; Preston K
    Exp Neurol; 2000 Apr; 162(2):290-6. PubMed ID: 10739635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.